Sort
48,018 grants matching “immunotherapy”
LEVERAGING T-CELL METABOLISM TO IMPROVE ANTICANCER IMMUNOTHERAPIES
$615,928University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2019 · Defense Health Agency
Developmental Funds
$615,923Leonidas C Platanias · Northwestern University At Chicago · P30 · FY2020 · CA
Developmental Funds
$615,923Leonidas C Platanias · Northwestern University At Chicago · P30 · FY2021 · CA
Developmental Funds
$615,923Leonidas C Platanias · Northwestern University At Chicago · P30 · FY2022 · CA
Developmental Funds
$615,923Leonidas C Platanias · Northwestern University At Chicago · P30 · FY2019 · CA
Impact of mutation burden on cancer growth and the immune landscape
$615,901Eileen White · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay
$615,852Yun Wu · State University Of New York At Buffalo · R01 · FY2024 · CA
Identifying senescence and immune biomarkers predictive of benefit to combined CDK4 and checkpoint blockade inhibition in patients with dedifferentiated liposarcoma
$615,811Sandra P D'angelo · Sloan-Kettering Inst Can Research · R01 · FY2023 · FD
MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors
$615,777Jeremy J Heit · Stanford University · R01 · FY2021 · CA
DEVELOPING MULTI-ANTIGEN VACCINE FOR THE TREATMENT OF CHRONIC HBV
$615,763Valerian Nakaar · Carogen Corporation · R44 · FY2019 · DK
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma
$615,760Evan Newell · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Translational Regulation of T Regulatory Cells
$615,670Robert Schneider · New York University School Of Medicine · R01 · FY2020 · AI
GM-CSF, macrophages, and susceptibility to Mycobacterium abscessus pulmonary infection
$615,656Katherine B Hisert · National Jewish Health · R01 · FY2023 · HL
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic Leukemia
$615,576Kara Lynn Davis · Stanford University · R01 · FY2021 · CA
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
$615,450Vinod P Balachandran · Sloan-Kettering Inst Can Research · U01 · FY2020 · CA
Novel therapeutic approaches for enhancing anti-tumor immunity in SCLC
$615,425John V. Heymach · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · CA
Novel approach to modulate the TME on-demand with therapeutic peptides and proteins.
$615,399Kit S Lam · University Of California At Davis · R01 · FY2025 · CA
Dissecting neoepitope-specific clonal T cell populations in advanced melanoma patients vaccinated with personal neoantigen peptides partnered with local and systemic immune checkpoint Inhibition
$615,390Patrick Alexander Ott · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Design-driven engineering of robust mammalian sense-and-respond functions: from parts to programs
$615,361Joshua Nathaniel Leonard · Northwestern University · R01 · FY2023 · EB
Tumor evolution in response to treatment
$615,334Lichun Ma · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma
$615,301Dara L Kraitchman · Johns Hopkins University · R01 · FY2022 · CA
MRI-Guided Cryoablation and Imaging-Guided Intratumoral Delivery of STING Agonist Immunotherapy to Target Localized and Metastatic Canine Osteosarcoma
$615,301Dara L Kraitchman · Johns Hopkins University · R01 · FY2023 · CA
An Integrated In Vitro 3D Model of Human Bone Marrow and Peripheral Infection
$615,220Steven Carl George · University Of California At Davis · R01 · FY2023 · EB
Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients
$615,176Yvonne L Kapila · University Of California Los Angeles · R01 · FY2023 · CA
Processed Antigen Characterization by Mass Spectrometry
$615,162Donald F Hunt · University Of Virginia · R01 · FY2017 · AI